Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Minerva Cardioangiologica 2017 August;65(4) > Minerva Cardioangiologica 2017 August;65(4):348-54

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA CARDIOANGIOLOGICA

Rivista sulle Malattie del Cuore e dei Vasi


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

ORIGINAL ARTICLE  


Minerva Cardioangiologica 2017 August;65(4):348-54

DOI: 10.23736/S0026-4725.17.04321-3

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Combination of endovascular graft exclusion and drug therapy in AAA with hypertension or hyperglycemia

Dile WANG, Bihui QU, Tao HE

Department of Vascular Surgery, Key Laboratory for Molecular Diagnosis of Hubei Province, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China


PDF  


BACKGROUND: The objective of the present study was to evaluate the efficacy of combination of endovascular graft exclusion and drugs for hypertension/hyperglycemia for the treatment of abdominal aortic aneurysm (AAA).
METHODS: We analyzed 156 patients with AAA. Eighty-four patients were hypertensive and 72 were hyperglycemic. After endovascular graft exclusion, hypertensive patients were divided into four groups and treated with cyclopenthiazide, reserpine, propranolol, and placebo respectively. Hyperglycemic patients were divided into three groups and treated with metformin, insulin, and placebo respectively. Body temperature and peripheral blood leukocytes were measured at day 1, 2, 7, and 14 after endovascular graft exclusion. Size of AAAs, blood pressure, and blood sugar were measured again after 1 year.
RESULTS: In hypertensive patients, the size of AAAs reduced after endovascular graft exclusion, while the combined treatments with cyclopenthiazide, reserpine, or propranolol helped to reduce blood pressure (blood pressure decrease <10 mmHg (18/21), <10 mmHg (12/21), <10 mmHg (8/21), and <10 mmHg (10/21) in the control group, cyclopenthiazide group, reserpine group, and propranolol group, respectively. AAA size decreased in the control group (P<0.001) and in the other three groups (P<0.0001). Similar results were obtained in hyperglycemic patients. The size of AAAs reduced after endovascular graft exclusion. Combined treatment with Metformin and Insulin reduced blood sugar (control, blood sugar >7.8 mmol/L (22/24), AAA size (P<0.001); metformin, blood sugar >7.8 mmol/L (14/24), AAA size (P<0.0001); insulin, blood sugar >7.8 mmol/L (11/24), AAA size (P<0.0001).
CONCLUSIONS: Combination of endovascular graft exclusion with medicine is more effective than the former treatment alone for AAA therapy.


KEY WORDS: Abdominal aortic aneurysm - Vascular grafting - Drug therapy

inizio pagina

Publication History

Issue published online: June 16, 2017
Article first published online: January 31, 2017
Manuscript accepted: January 3, 2017
Manuscript received: December 27, 2016

Per citare questo articolo

Wang D, Qu B, He T. Combination of endovascular graft exclusion and drug therapy in AAA with hypertension or hyperglycemia. Minerva Cardioangiol 2017;65:348-54. DOI: 10.23736/S0026-4725.17.04321-3

Corresponding author e-mail

taohewuhan@sina.com